MLIP

protein-coding

muscular LMNA interacting protein

Gene summary

Predicted to enable lamin binding activity and transcription corepressor activity. Predicted to be involved in negative regulation of cardiac muscle hypertrophy in response to stress; negative regulation of transcription by RNA polymerase II; and positive regulation of transcription by RNA polymerase II. Predicted to be located in PML body; nuclear envelope; and sarcolemma. Implicated in myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis 1. [provided by Alliance of Genome Resources, Jun 2026]

Previous symbols:
  • C6orf142

MANE transcript

NM_001281747.2

Inheritance

AR

ClinVar variants

P:18U:57B:18

Top phenotype

Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis 1

gnomAD constraint

pLI —, LoF o/e 0.99

Max pathogenic AF

—

Genomic locus

chr6:53,929,982-54,266,280

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~336.3 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis 1STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0859322

Submitter: Ambry Genetics

myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis 1STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0859322

Submitter: PanelApp Australia

myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis 1STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0859322

Submitter: Labcorp Genetics (formerly Invitae)

Clinical Genomic Database (CGD)

Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis 1AR

Manifestation: Cardiovascular; Musculoskeletal

Intervention: Cardiovascular; Musculoskeletal

Rationale: The condition can involve cardiomyopathy and/or arrhythmia, and awareness may allow prompt diagnosis and mangement; Individuals may be at risk of rhabdomyolysis, and awareness may allow avoidance of precipitating factors, and prompt treatment of episodes

Refs: 34581780; 34935254; 35672413; 35915960Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to MLIP variants in ClinVar

7 Conditions Cataloged
Inborn genetic diseasesTotal: 50
not providedTotal: 19
MLIP-related disorderTotal: 16
Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysisTotal: 12
not specifiedTotal: 5
Intellectual developmental disorder, autosomal dominant 64Total: 1
Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis 1Total: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_001281747.2. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
7
clinvar
1
clinvar
8
missense
56
clinvar
8
clinvar
2
clinvar
66
nonsense
5
clinvar
5
start loss
0
frameshift
5
clinvar
6
clinvar
11
splice donor/acceptor (+/-2bp)
2
clinvar
1
clinvar
3
Total1085715393

Highest pathogenic variant AF is 0.0002092428

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 43 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_001281747.2RefSeqNP_001268676.114MANE Select
ENST00000502396.6EnsemblENSP00000426290.114MANE Select
NM_001281746.2RefSeqNP_001268675.112Standard
NM_138569.3RefSeqNP_612636.213Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Biological Process

  • negative regulation of transcription by RNA polymerase II
  • negative regulation of cardiac muscle hypertrophy
  • positive regulation of transcription by RNA polymerase II
  • negative regulation of cardiac muscle hypertrophy in response to stress

Cellular Component

  • nucleus
  • nuclear envelope
  • PML body
  • nuclear lumen
  • sarcolemma

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000274897
Coding exons
13
Length
336299
Individuals with no LoFs
125703
Homozygous LoFs
0
Heterozygous LoFs
44
Defined
125747
p
0.000175
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense-0.7102662351.130.00001142964
Missense (PolyPhen)8488.3410.950861145
Synonymous-0.6139789.61.080.00000462895
Loss of Function0.05562424.30.9880.00000108320

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000320.00031rare
Latino/Admixed American0.000290.00026rare
Ashkenazi Jewish00.0absent
East Asian0.000110.00011rare
Finnish00.0absent
European (Non-Finnish)0.000160.00016rare
South Asian0.000330.00033rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Required for precocious cardiac adaptation to stress through integrated regulation of the AKT/mTOR pathways and FOXO1. Regulates cardiac homeostasis and plays an important role in protection against cardiac hypertrophy. Acts as a transcriptional cofactor, represses transactivator activity of ISL1 and MYOCD. {ECO:0000250|UniProtKB:A0A096MK47, ECO:0000250|UniProtKB:Q5FW52}.;

Intolerance Scores

RVIS EVS
0.24
RVIS percentile EVS
69.51

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
N
Indispensability score
0.114

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.